• Home
• About
  • Mandate and Functions
  • Membership
  • INCB President
  • INCB Secretariat
  • INCB Sessions
• News and Media
  • Alerts
  • Missions and Activities
  • Newsletter
  • Press Releases
  • Statements
• Conventions
  • 1961 Convention
  • 1971 Convention
  • 1988 Convention
• Contact
  • Contact Form

• Narcotic Drugs
• Psychotropic Substances
• Precursors
• Global Programmes
• Treaty Compliance
• Annual Report

• Publications
• Guidelines
• Travellers
• Tools
• Links
• COVID-19

• Secure Areas

Cornelis P. de Joncheere

Born in 1954. National of the Kingdom of the Netherlands. Currently Chair of the Netherlands Antibiotics Development Platform and a consultant to WHO on pharmaceutical policies.

Doctor of Pharmacy (PharmD) and Master of Science (MSc) in Pharmacy, University of Groningen and University of Amsterdam, Kingdom of the Netherlands (1975-1981); Master's in Business Administration, University of San Diego, United States/San José, Costa Rica; Bachelor of Science (BSc). Pharmacy, cum laude (honour student), University of Groningen, Kingdom of the Netherlands (1972-1975).

Previously held positions as Director, Department of Essential Medicines and Health Products at WHO, Geneva (2012-2016), which included work on access to controlled medicines, and the WHO Expert Committee on Drug Dependence; WHO Representative, Kyiv (2011-2012); WHO Regional Adviser for Pharmaceuticals and Health Technologies, WHO Regional Office for Europe, Copenhagen (1996-2010); National Essential Drugs Programme Coordinator, Pan American Health Organization (PAHO)/WHO, Brazil (1994-1996); Pharmacist, Essential Drugs Projects Coordinator, PAHO/WHO, Costa Rica (1988-1993); Pharmaceutical expert, PAHO/WHO, Panama (1986-1988); pharmaceutical supply expert in North Yemen, Ministry of Foreign Affairs, Directorate for International Cooperation, Kingdom of the Netherlands (1982-1985); hospital and community pharmacy in Amsterdam (1981-1982).

President of the WHO Europe Staff Association (2006-2010); member of the WHO Guidelines Review Committee  (2007-2011); member of the Royal Dutch Pharmaceutical Society; author and co-author of numerous publications in the fields of pharmaceutical and health sciences.

Member of the International Narcotics Control Board (since 2017) [1]. Rapporteur (2017, 2023 and 2025). Member of the Standing Committee on Estimates (2017-2018, 2021-2022 and 2024-2025). Member (2017-2018 and 2021) and Chair (2022 and 2024) of the Committee on Finance and Administration. Chair (2025) of the Standing Committee on GRIDS and Related Programmes. President of the Board (2019-2020).